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MALDI-TOF mass-spectrometryGlycosylated cell penetrating peptides (CPPs) have been conjugated to a peptide cargo and the efﬁciency of
cargo delivery into wild type Chinese hamster ovary (CHO) and proteoglycan deﬁcient CHO cells has been
quantiﬁed by MALDI-TOF mass spectrometry and compared to tryptophan- or alanine containing CPPs. In
parallel, the behavior of these CPPs in contact with model membranes has been characterized by different
biophysical techniques: Differential Scanning and Isothermal Titration Calorimetries, Imaging Ellipsometry
and Attenuated Total Reﬂectance IR spectroscopy. With these CPPs we have demonstrated that tryptophan
residues play a key role in the insertion of a CPP and its conjugate into the membrane: galactosyl residues
hampered the internalization when introduced in the middle of the amphipathic secondary structure of a
CPP but not when added to the N-terminus, as long as the tryptophan residues were still present in the se-
quence. The insertion of these CPPs into membrane models was enthalpy driven and was related to the num-
ber of tryptophans in the sequence of these secondary amphipathic CPPs. Additionally, we have observed a
certain propensity of the investigated CPP analogs to aggregate in contact with the lipid surface.
© 2011 Elsevier B.V. All rights reserved.1. Introduction
Cell penetrating peptides (CPPs)with their capacity to shuttle cargoes
inside cells are regarded as a sort of “magic bullets” for intracellular deliv-
ery of bioactive molecules, even though their intracellular localization is
dependent on their mechanism(s) of entrance: direct translocation of
the plasma membrane or endocytotic pathways [1–6]. In search ofReﬂection Spectroscopy; CPP,
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l rights reserved.some speciﬁcity in addressing CPPs, we have studied the effect of CPP
myristoylation on the delivery of a peptide cargo. Myristoylation of com-
monly used CPPs and synthetic dendrimers showed an increase in con-
veying a cargo inside CHO cells [7,8]. Recently, we have explored the
inﬂuence of glycosylation of a CPP sequence on cargo delivery, taking as
a starting point our lead CPP: Ac-RRWWRRWRR-NH2 [9]. Glycosylation
of bioactive compounds has been used mainly for increasing the hydro-
philicity, the enzymatic stability, and/or the delivery into the brain
[10–12]. In the context of CPPs, we have hypothesized that glycosylation
could regulate the binding to the plasma membrane of CPPs and conju-
gates and consequently their internalization pathway and/or speciﬁcity.
In our previous study, the pro-apoptotic KLAK peptide (KLAKLAK)2,
was conjugated via a labile disulﬁde linker to analogs of the CPP Ac-C-
RRWWRRWRR-NH2, these analogs possessing galactosyl unit(s) in-
stead of the indole side-chains of the tryptophans [13]. Cell viability
studies showed an inverse relationship with the number of galactosyl
moieties, the conjugate, Ac-C-RRA(βtGal)A(βtGal)RRA(βtGal)RR-NH2,
with three galactoses and no tryptophan, did not induce CHO cell
death. Furthermore, ﬂuorescence studies performed in parallel showed
that the KLAK peptide was not delivered inside the cells with this
galactosyl-substituted peptide. This correlation between cell death
and cellular uptake of the cargowas also observed for the other glycosy-
lated vectors studied [13]. Rothbard et al. have shown that analogs of
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neously modiﬁed in positions 2, 5 and 8 by proteinogenic or modiﬁed
amino acids (Trp and Cys were not tested), except the two analogs
with acidic residues: Arg7/Asp3 and Arg7/Glu3, which “entered cells rel-
atively poorly” [14]. The aim of the present studywas to aid in the iden-
tiﬁcation of the structural, physico-chemical and thermodynamic
parameters relevant for cellular uptake. For this, we have quantiﬁed
the efﬁciency of cargo delivery of glycosylated CPPs into cells and ana-
lyzed by different techniques their interactions with model membranes.
The glycosylated CPPs studied previously ((3) and (4), (Table 1)) were
conjugated to a peptide inhibitor of protein kinase C (PKCi) [7,15–17].
We have also synthesized a new glycosylated CPP (5) with three galac-
tose units on the N-terminus of the Arg/Trp sequence, and a control
Arg/Ala peptide (2), suspecting that tryptophan residues were playing
an essential role in the internalization process.
Herein, we report the quantiﬁcation by MALDI-TOF mass spec-
trometry [18,19] of the PKCi cargo internalized into wild type CHO
and proteoglycan deﬁcient CHO cells [4]. Indeed many studies
showed that CPPs bind to glycosaminoglycans (GAGs) with signiﬁ-
cant afﬁnity [20–22] and that GAGs are involved in CPPs internaliza-
tion pathways [4,23]. In parallel, we have characterized by different
biophysical techniques (DSC, ITC, Imaging Ellipsometry and ATR)
the behavior of the glycosylated CPPs in contact with LUVs and lipid
monolayers. Our results show a clear correlation between the efﬁ-
ciency of internalization, the presence of tryptophan residues on the
CPP sequence and an enthalpy gain resulting from the energetically
favorable transfer of Trp residues from the aqueous solution to the in-
terior of the lipid bilayer.2. Material and methods
2.1. Peptide syntheses
Rink amide (p-methylbenzhydrylamine)-resin (MBHA-resin,
100–200 mesh), (4-(2′-4′-dimethoxyphenyl-Fmoc-aminomethyl)-phe-
noxyacetamido-norleucyl-MBHA polystyrene resin, 0.64 mmol/g),
O-(benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexaﬂuoropho-
sphate (HBTU), Fmoc-Cys(S-StBu)-OH, Fmoc-Arg(Pbf)-OH, Fmoc-Trp
(Boc)-OH and Fmoc-Ala-OH were purchased from Novabiochem.
Fmoc-Pra-OH was purchased from IRIS Biotech. Peptides were charac-
terized by MALDI-TOF MS (DE-Pro, ABI) in positive ion reﬂector mode
using the matrix CHCA. The m/z of the protonated molecules is given
as experimental and calculated in Table 2. Proteomix 4 (Laserbio Labs)
[500–3500 Da] was used for calibration.Table 1
Sequences of the cell-penetrating peptides and the corresponding PKCi conjugates.
N° Sequence
(1) Ac-C(S-Acm)RRWWRRWRR-NH2
(2) Ac-C(S-Acm)RRAARRARR-NH2
(3) Ac-C(S-Acm)RRWA(βtGal)RRWRR-NH2
(4) Ac-C(S-Acm)RRA(βtGal)A(βtGal)RRA(βtGal)RR-NH2
(5) Ac-A(βtGal)A(βtGal)A(βtGal)C(S-Acm) RRWWRRWRR-NH2
(1′) Biot(O2)-GGGGC(S-S(NAc)CRRWWRRWRR-NH2)-RFARKGALRQKNV-NH2
(2′) Biot(O2)-GGGGC(S-S(NAc)CRRAARRARR-NH2)-RFARKGALRQKNV-NH2
(3′) Biot(O2)-GGGGC(S-S(NAc)CRRWA(βtGal)RRWRR-NH2)-RFARKGALRQKNV-
NH2
(4′) Biot(O2)-GGGGC(S-S(NAc)CRR(βtGalA)(βtGalA)RR(βtGalA)RR-NH2)-
RFARKGALRQKNV-NH2
(5′) Biot(O2)GGGGC(S-S(NAc-A(βtGal)A(βtGal)A(βtGal))CRRWWRRWRRNH2)-
RFARKGALRQKNV-NH2
Acm:\CH2\C(O)\NH2; Biot(O2): biotine sulfone; A(βtGal): β-(1H,3-galactosyl-[1-3]
triazol)alanine and PKCi: RFARKGALRQKNV. CPP sequences are represented in italic in
the table for a better visualization within the sequences of the conjugates with PKCi.2.1.1. Ac-C-RRAARRARR-NH2
Ac-C(S-StBu)-RRAARRARR-NH2 was synthesized manually by solid-
phase methodology on a Rink amide resin (0.64 mmol/g) by Fmoc strat-
egy in a fritted syringe. Fmoc protection was removed with a solution of
piperidine in NMP (20%, 3×5min). Stepwise coupling reactions were
performed with Fmoc-protected amino acids, HBTU and DIPEA (3/2.85/
3 eq) at RT. After removal of the last Fmoc protecting group, the peptide
was N-acetylated with a solution of acetic anhydride in NMP (20%,
45 min). The resin was washed with NMP, CH2Cl2, CH3OH and dried
under vacuum. The resin was then treated with TFA/H2O/TIS: 95/2.5/2.5
(15 mL/g resin, 2 h, RT), the cleaved peptide precipitated in diethyl
ether, lyophilized and puriﬁed by RP-HPLC on a preparative C8 column
using a 30 min linear methanol (0.1% TFA) gradient in an aqueous solu-
tion (0.1% TFA) to yield the product as awhite powder after lyophilisation
(20% yield). The purity of the peptide was determined by analytical
RP-HPLC on a C8 column using a linear methanol (0.1% TFA) gradient in
an aqueous solution (0.1% TFA). Retention time of the product was
15.7 min (0–100%methanol over 30 min). The peptidewas characterized
by MALDI-TOF MS: (m/z) [MH]+ calcd 1400.80, found 1400.90.
DTT (20 eq) was added to Ac-C(S-StBu)-RRAARRARR-NH2, dis-
solved in a degassed solution of Tris–HCl 50 mM (~2 mM), and the
reaction was stirred at RT for 2 h. The reaction was monitored by
RP-HPLC. Crude thiol peptide was then puriﬁed by RP-HPLC on a pre-
parative C8 column using a linear methanol (0.1% TFA) gradient in an
aqueous solution (0.1% TFA) to yield the product as a white powder
after lyophilisation (9% yield). Peptide purity was analyzed by analyt-
ical RP-HPLC on a C8 column using a linear methanol (0.1% TFA) gra-
dient in an aqueous solution (0.1% TFA). Retention time of the
product was 9.8 min (0–100% methanol over 30 min). The peptide
was characterized by MALDI-TOF MS: (m/z) [MH]+ calcd 1312.76,
found 1312.56.2.1.2. Ac-A(βtGal)A(βtGal)A(βtGal)-C-RRWWRRWRR-NH2
Ac-Pra-Pra-Pra-C(S-StBu)-RRWWRRWRR-NH2 was synthesized
manually by solid-phase methodology on a Rink amide resin
(0.64 mmol/g) by Fmoc strategy in a fritted syringe. Fmoc protection
was removed with a solution of piperidine in NMP (20%, 3×5 min).
Stepwise coupling reactions were performed with Fmoc-protected
amino acids, HBTU and DIPEA (3/2.85/3 eq) at RT. After removal of the
last Fmoc protecting group, the peptidewasN-acetylatedwith a solution
of acetic anhydride in NMP (20%, 45 min). The resin was washed with
NMP, CH2Cl2,MeOHanddried under vacuum. For analysis, approximate-
ly 5 mg of the resin was treated with TFA/H2O/TIS: 95/2.5/2.5 (15 mL/g
resin, 2 h, RT), the peptide precipitated in diethyl ether, lyophilized
and analyzed by analytical RP-HPLC on a C8 column using a linear meth-
anol (0.1% TFA) gradient in an aqueous solution (0.1% TFA). Retention
time of the product was 9.8 min (0–100% methanol over 30 min). The
pure peptide was characterized by MALDI-TOF MS (m/z) [MH]+calcd
2031.04, found 2031.1.
In a fritted syringe CuI (15 eq), ascorbic acid (15 eq), the azido-sugar:
1-azido-2,3,4,6-tetra-O-acetyl-β-(D)-galactopyranoside (6 eq) [13] and
a degassed solution of DMF(anhydrous)/2,6-lutidine (7/3) containing
DIPEA (21 eq) were added to the dried Pra containing-peptidyl-resin,
Ac-Pra-Pra-Pra-C(S-StBu)-RRWWRRWRR-resin (0.023 M). The solution
was sonicated for 5 min and shaken for 15 h at RT. The resin was then
washed with DMF, DMF/Pyridine (6/5) containing ascorbic acid
(0.02 g/mL), CH2Cl2 and MeOH. The resin was dried under vacuum and
then cleaved using TFA/H2O/TIS: 95/2.5/2.5. Analytical RP-HPLC showed
complete conversion of the peptide into the glycopeptide. The major
peak in the HPLC spectra was identiﬁed as the expected product.
RP-HPLC retention time of the crude product was ~16.5 min (30–100%
methanol over 30 min). MALDI-TOF MS: (m/z) [MH]+ calcd 3150.37,
found 3150.56. This peptide, Ac-A(βtGal(OAc))A(βtGal(OAc)A(βtGal
(OAc))-C(S-StBu)-RRWWRRWRR-NH2 was used directly for the next
step.
Table 2
Characterization of cell-penetrating peptides (1–5) and conjugates (1′–5′).
N° Yielda RP-HPLC, retention time gradientb MALDI-TOF MS (m/z)
[M,H]+ (calculated)c
(1) 57% 16.2 min
(0–100% MeOH)
[M,H]+: 1714.91 (calc. 1714.91)
(2) 51% 8.5 min
(0–100% MeOH)
[M,H]+: 1369.77 (calc. 1369.79)
(3) 40% 14.5 min
(0–100% MeOH)
[M,H]+: 1829.32 (calc. 1828.94)
(4) 60% 8.2 min
(0–100% MeOH)
[M,H]+: 2057.15 (calc. 2056.99)
(5) 26% 18 min
(0–100% MeOH)
[M,H]+: 2615.96 (calc. 2615.23)
(1′) 51% 14.6 min
(0–60% MeCN)
[Ac-C(SH)RRWWRRWRR,H]+: 1657.54 (calc. 1657.89); [PKCi-SH,H]+: 2132.37 (calc. 2132.10)
(2′) 47% 15.8 min
(0–100% MeOH)
Ac-C(SH)RRAARRARR, H]+: 1312.20 (calc. 1312.76); [PKCi-SH,H]+: 2131.68 (calc. 2132.10)
(3′) 45% 14.7 min
(0–100% MeOH)
[Ac-C(SH)RRWA(βtGal)RRWRR,H]+: 1772.77 (calc. 1772.93); [PKCi-SH,H]+: 2131.96 (calc. 2132.10)
(4′) 51% 11.0 min
(0–100% MeOH)
[Ac-C(SH)RRA(βtGal)A(βtGal)RRA(βtGal)RR,H]+: 1999.98 (calc. 1999.97); [PKCi-SH,H]+: 2132.10 (calc. 2132.10)
(5′) 54% 13.9 min
(0–60% MeCN)
[Ac-A(βtGal)A(βtGal)A(βtGal)C(SH)RRWWRRWRR,H]+: 2557.40 (calc. 2558.21); [PKCi-SH,H]+: 2131.57 (calc. 2132.10)
a The yields reported herein correspond to the last step: protection of the thiol function for peptides (1–5) and coupling with the PKCi cargo for peptides (1′–5′) and the sub-
sequent RP-HPLC puriﬁcation.
b (min) linear gradient over 30 min as indicated.
c The value reported in italic between brackets corresponds to the calculated mass as [M,H]+.
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(βtGal(OAc))-C(S-StBu)-RRWWRRWRR-NH2were removedwith a solu-
tion of NH4OH (28%) in THF/MeOH (1/2/2, HO- concentration ~7 mM).
The reaction was followed until its completion by RP-HPLC using a linear
methanol (0.1% TFA) gradient in an aqueous solution (0.1% TFA).
RP-HPLC showed two main products corresponding to the deacetylated
peptides with different amounts of the Cys(S-StBu) and the deprotected
cysteine. After evaporation of THF and CH3OH and lyophilization of the
residual aqueous solution, the mixture of peptides (corresponding to
the presence of the deprotected and the protected cysteine CysS-StBu)
was dissolved in a degassed solution of Tris–HCl 50 mM (~2 mM). DTT
(20 eq) was added and the reaction was stirred at RT for 2 h. Ac-A
(βtGal)A(βtGal)A(βtGal)-C-RRWWRRWRR-NH2 was puriﬁed by
RP-HPLC on a preparative C8 column using a linear methanol (0.1%
TFA) gradient in an aqueous solution (0.1% TFA). Peptide purity was ana-
lyzed by analytical RP-HPLC with a C8 column using a linear acetonitrile
(0.1% TFA) gradient in an aqueous solution (0.1% TFA). Retention time
of the product was 17.0 min (0–100% methanol over 30 min). The pep-
tide was characterized by MALDI-TOF MS: (m/z) [MH]+ calcd 2558.21,
found 2557.76. Overall yield (peptide synthesis, click chemistry, deacety-
lation, Cys(S-StBu) deprotection and puriﬁcation) was 1.8%.
2.1.3. Syntheses of peptides (1–5)
To a solution (~1–2 mM) of the different CPP, with a deprotected cys-
teine, dissolved under argon in carefully degassed Tris–HCl (50 mM)
were added TCEP (3 eq) and iodoacetamide (50 eq). The solutions were
then homogenized using an argon ﬂux (bubbling for 3 min) and air
above the reaction mixture was saturated with argon. After stirring in
the dark, completion of the reactions were determined by HPLCmonitor-
ing. The retention times of the starting and expected peptides were quite
similar and co-injection was often necessary to be sure of the peak iden-
tiﬁcation. The peptideswere puriﬁed by RP-HPLCwith a C8 column using
a linear acetonitrile or methanol (0.1% TFA) gradient in an aqueous solu-
tion (0.1% TFA). Peptides were analyzed by analytical RP-HPLC with a C8
column using a linear acetonitrile or methanol (0.1% TFA) gradient in an
aqueous solution (0.1% TFA) and characterized by MALDI-TOF MS (m/z).
2.1.4. Syntheses of the conjugates (1′–5′)
The CPPs with a SH-free cysteine, prepared as described above for
the obtention of peptides (1) and (5), were dissolved under argonbubbling in a carefully degassed 10% acetic acid solution and mixed
with a slight excess (1.2 eq) of peptide Biot(O2)-GGGG-C(Npys)-
RFARKGALRQKNV-NH2. Completions of the reactions were monitored
by RP-HPLC. Usually reaction times comprised between 12 h and 24 h
without stirring were necessary. The conjugates were puriﬁed by
RP-HPLC on a preparative C8 column using a linear acetonitrile or
methanol (0.1% TFA) gradient in an aqueous solution (0.1% TFA). Pep-
tides were puriﬁed by analytical RP-HPLC using a C8 column with a
linear acetonitrile or methanol (0.1% TFA) gradient in an aqueous so-
lution (0.1% TFA) and characterized by MALDI-TOF MS.
2.2. Internalization of the conjugates
2.2.1. Cell Culture [4]
Wild type (CHO-K1) and xylose transferase deﬁcient (pgsA745)
Chinese hamster ovary cells were obtained from the American Type
Culture Collection (Manassas, VA). All cell lines were grown under
an atmosphere of 5% CO2 in air and 100% relative humidity in F12
growth medium (DMEM) supplemented with 10% (v/v) fetal bovine
serum, 100 μg/mL of streptomycin sulfate, amphotericin B, and 100
units/mL of penicillin G.
2.2.2. Measure of the cellular uptake by MALDI-TOF mass spectrometry
The internalization experiments were performed as described
previously [18,19]. The conjugates contain an isotope tag (Biot(O2)-
GGGG), located on the N terminus of the cargo of the PKCi peptide
(Table 1 and Fig. 1) to allow absolute quantiﬁcation by MALDI-TOF
MS. Two PKCi peptide analogs were synthesized, one with four non-
deuterated glycines (1H-peptide) and one with four deuterated gly-
cines (2H-peptide). One million adherent cells were incubated at
37 °C for 75 min with the conjugate 1H-peptide (5 μM) in culture me-
dium (without fetal calf serum). After washing with culture medium,
cells were treated with a TCEP solution for 3 min (2 mM TCEP in
50 mM Tris, pH 7.5) to reduce the PKCi species linked by a disulﬁde
bridge to cell surface thiols [24,25]. Trypsin was then added to de-
grade the remaining extracellular and membrane-bound peptide
and to detach cells. After addition of enzyme inhibitors mixed with
bovine serum albumin, cells were transferred to a microtube, centri-
fuged, and washed with Tris buffer. The cells were then lysed in a so-
lution containing a controlled and relevant quantity of the chemically
Fig. 1. General formula of PKCi-CPP disulﬁde conjugates (1′) to (5′), with CPP sequence
indicated in italic in Table 1, and formula of the alanyl-modiﬁed residue: A(βtGal).
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dard to quantify by MALDI-TOF the internalized amount of 1H-CPP). The
samplewas thenboiled for 15 min to inhibit intracellular protease activity
and to destroy potential PKCi intracellular partners molecular interac-
tions. The biotinylated PKCi analogs (1H and 2H) were then puriﬁed
with streptavidin-coated magnetic beads and eluted with the α-cyano-
4-hydroxy cinnamic acid matrix before MALDI-TOF MS analysis. The
amount of intact internalized PKCi was calculated from the area ratio of
the [M+H+] signals of intact 1H-peptide and 2H-peptide. The 1H- and
2H-peptides are separatedby8 atomicmassunits, so therewasnooverlap
of their signals on the mass spectra. As for standard quantity, we found
quantiﬁcation to be more accurate when the 1H-PKCi/2H-PKCi signals
ratio ranged from 0.2 to 5. In addition, for each experiment, we used du-
plicate or triplicate wells, and the experiments were independently re-
peated for at least three times, as indicated in the ﬁgures. The minimal
amount, which can be conﬁdently determined, was around 0.5 pmol of
intact peptide, corresponding to intracellular concentrations around
0.5 μM (mean volume of 1 pl per CHO cell). The trypsinization step was
omitted for the determination of the membrane-bound peptide. Mix 4
(ou Proteomix): [500–3500 Da] was used for peptide calibration.
2.3. Biophysical studies
2.3.1. Preparation of MLVs and LUVs
Lipid ﬁlms were made by dissolving the appropriate amount of
lipids into CHCl3 or a mixture of CHCl3 and CH3OH (2/1, vol/vol). The
solvent was then evaporated under N2 to deposit the lipid as a ﬁlm on
thewall of a test tube. Final traces of solventwere removed in a vacuum
chamber attached to a liquid nitrogen trap during 3–4 h. Films were
then hydrated with 10 mM Tris, 0.1 M NaCl, 2 mM EDTA, pH 7.5 for
DSC and ITC experiments. The ﬁlms were then vortexed extensively at
a temperature superior to the phase transition temperature of the
lipid to obtain MLVs. To form LUVs, the MLVs were subjected to ﬁve
freeze/thawing cycles. The homogeneous lipid suspension was passed
10 times through a nitrogen pressure driven extruder (LIPEX, Northern
Lipids Inc., BC) equipped with a 100 nm polycarbonate membrane at a
temperature above the phase transition temperature of the lipid.
2.3.2. Differential scanning calorimetry (DSC) experiments
DSC experiments were performed on a high-sensitivity calorimeter
(TA Instruments). The different peptides were gradually added to the
same sample of lipid MLVs to obtain peptide/lipid molar ratios of 1/
100, 1/50, 1/25 and 1/10. The lipid concentration was 1 mg/mL, ca.
1.45 mM. For each peptide concentration, a minimum of four heating
and four cooling scans were performed so that equilibrium is reached.
A scan rate of 1 °C/min was used and there was a delay of 10 min be-
tween sequential scans in a series to allow thermal equilibration. Data
analysis was performed by the ﬁtting program NanoAnalyze provided
by TA Instruments.2.3.3. Isothermal titration calorimetry (ITC) experiments
ITC experiments were performed on a TA Instrument nano ITC calo-
rimeter. To avoid air bubbles, peptide and LUV solutions were degassed
under vacuum before use. Titrations were performed by injecting ali-
quots of LUVs (lipid concentration varying between 6.24 mM and
3.12 mM) into the calorimeter cell containing the peptide solution (pep-
tide concentration 0.1 mMexcept for (5) 0.048 mM),with 5 minwaiting
between injections. The experiments were performed at 25 °C. Data
analysis was performed using the program NanoAnalyze provided by
TA Instruments.2.3.4. Surface pressure measurements and Imaging Ellipsometry
Monolayer experimentswere performed in a Teﬂon circular Langmuir
trough (V=12mL, ø=6.5 cm). The surface pressure was measured
using the Wilhelmly method using a ﬁlter paper plate. All the experi-
ments were performed at 27±2 °C. The trough was ﬁlled with 20 mM
Tris, 150mM NaCl buffer, pH 7.5. Monolayers were obtained by deposit-
ing few μL of a lipid mixture (DMPC in CHCl3 or DMPC/DMPG 80/20 in
CHCl3/CH3OH, 2/1) at the air/buffer interface until the surface pressure
reached a value between 25 and 28 mN/m. Fifteen microliters of each
peptide in solution (1 mM) in the same buffer was then injected under
the monolayer into the subphase as three successive injections and the
surface pressurewasmonitored continuously. At the same time, themor-
phology of the interface was observed using an Imaging Ellipsometer
(NFT iElli-2000) mounted on the Langmuir trough. The microscope was
equipped with a frequency-doubled Nd:Yag laser (532 nm, 55 mW), a
polarizer, an analyzer and a CCD camera. The spatial resolution of the
BAMwas ~2 μm and the image size 570×450 μmwith 10× lens used.2.3.5. ATR spectra of the peptides in solution or in the presence of
phospholipid multibilayers
The ATR spectra of the peptide in solutionwere recorded on aNicolet
6700 spectrometer. For the spectra of the peptides alone in solution, the
spectrometerwas equippedwith a 3 reﬂexion diamond crystal. The pep-
tides were dissolved in a 20 mM Tris, 150 mMNaCl buffer, pH 7.5. Eight
hundred scanswere acquired at a resolution of 8 cm−1. The experiments
were performed at room temperature.
For the spectra of the peptides in the presence of multibilayers, the
spectrometer was equipped with a Germanium crystal thermostated at
30 °C. ATR spectroscopy is sensitive to orientation and therefore spectra
were recorded with a parallel (p) or perpendicular (s) polarization of
the incident light with respect of the ATR plate. 800 scans were coadded
at a resolution of 8 cm−1. Themultibilayer systemwas formed by depos-
iting 30 μL of a solution of DMPC/DMPG (80/20) in CHCl3/CH3OH, 2/1
(lipid concentration 0.5 mg/mL) on the surface of the crystal and the sol-
vents are left to evaporate. A p and an s spectrum are recorded to conﬁrm
that the system is well oriented and that no traces of chloroform are left.
The system is the re-hydrated by adding 20 μL of 20 mM Tris, 150 mM
NaCl, pH 7.5 buffer. One to 2 μL of peptide solution (1 mM) in the same
buffer is added, leading to a ﬁnal peptide concentration of 50 μM to
100 μM, and p and s spectra are recorded. The amide I frequencies
were attributed as follow: b1630 cm−1 antiparallel beta sheet,
1630–1635 cm−1 parallel beta sheet, 1640–1650 cm−1 random coil,
1650–1662 cm−1 alpha helix, 1662–1680 cm−1 beta turn.3. Results and discussion
All the peptides and their conjugates (Table 1, Fig. 1) were prepared
by Fmoc solid phase peptide synthesis. The galactosyl moieties were in-
troduced on a Pra-containing precursor (Fig. 2), aswe recently reported
[13]. All CPPs and conjugates were obtained with purity above 95%,
even though in some cases yields were sacriﬁced to ensure a better pu-
rity, and characterized by MALDI-TOF mass spectrometry (Table 2,
Fig. 3A).
Fig. 3. Examples of MALDI-TOF MS spectra. A) Peptide (3). B) Quantiﬁcation of membrane bound conjugate (1′). After treatment without the incubation step with trypsin (Cf. Ma-
terial and methods), the PKCi-SH peptide, Biot(O2)GGGGCRFARKGALRQKNV-NH2, was recovered after cells lysis in a solution containing a controlled and relevant quantity (here:
100 pmol) of the chemically identical deuterated form of the 2H-PKCi-SH peptide (Biot(O2)-[2H]G-[2H]G-[2H]G-[2H]G-C-RFARKGALRQKNV-NH2), which served as an internal stan-
dard to quantify the amount of 1H-CPP. The amount of the intact membrane bound plus the internalized PKCi was calculated from the area ratio of the [M,H+] signals of intact 1H-
PKCi-SH and 2H-PKCi-SH (found: 274 pmol). C) Quantiﬁcation of internalized PKCi with conjugate (5′). After treatment with the incubation step with trypsin (Cf. Material and
methods) the PKCi-SH peptide was recovered after cells lysis in a solution containing the [2H]-PKCi-SH peptide (here: 2 pmol). The amount of intact internalized PKCi was calcu-
lated from the area ratio of the [M,H+] signals of intact 1H-PKCi-SH and 2H-PKCi-SH (found: 3.2 pmol).
Fig. 2. Formula of peptides (4) and (5), as examples of galactosyl-linked triazole CPPs.
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wild type CHO (CHO-K1) and GAG-deﬁcient CHO (CHO-pgsA-745) cells
The PKCi cargo was used to quantify the efﬁciency of delivery of
our different carriers and not the KLAK cargo studied previously
[13] because this peptide is prone to aggregation. In addition the
KLAK peptide is not sensitive to the treatments used to distinguish
the internalized species from the membrane-bound species by
MALDI-TOF [18,19,24,25]. These two cargoes allowed us to study
the cell uptake of the different CPPs by two complementary strate-
gies: PKCi permitted a direct quantiﬁcation of the internalized
cargo, whereas using KLAK we showed that the studied CPPs could
transport a bioactive cargo and that a biological response could be ob-
served with different efﬁciencies according to the vector [13]. All the
CPPs (1–5) and conjugates (1′–5′) have the same N-terminus modiﬁ-
cations. The only difference within the sequence of CPPs (1–4) corre-
sponds to the gradual replacement of the tryptophan(s), and thus the
indole side-chain(s), by galactosyl moiety(ies). CPP (5) has three
tryptophans in the sequence and three galactosyl residues on the
N-terminus.
3.1.1. Quantiﬁcation of membrane-bound conjugates (1′–5′)
Conjugates (1′–5′) were incubated, at 5 μM, for 75 min with both
CHO cell types (106 cells). Cells were ﬁrst washed with culture medi-
um, then after cell lysis the amount of peptide was quantiﬁed by
MALDI-TOF, which corresponds to both the conjugate bound to the
cell membrane and internalized inside the cells. An example of this
quantiﬁcation is shown on Fig. 3B. The amount of conjugate bound
to the CHO-K1 cells ranged from 60 to 110 pmol, and similar data
were obtained with CHO pgsA-745 cells (60 to 70 pmol, whatever
the conjugate) (Fig. 4A).
These membrane-bound species correspond to peptides inserted
into the lipid bilayer or covalently linked to cell surface thiols
[24,25] or associated to high-afﬁnity binding sites in the membrane,Fig. 4. Quantiﬁcation of membrane-bound (A) and internalized (B) peptides for conju-
gates (1′) to (5′) using wild type CHO cells (black bars) and GAG-deﬁcient CHO cells
(white bars). Incubation conditions: 5 μM of conjugate with 106 cells at 37 °C for
75 min. The error bars represent the standard deviation (SD).such as sialic acid and/or lipids present on both wild type and GAG-
deﬁcient CHO cells. As previously quoted for CPPs alone, there is no
direct relationship between the amount of high-afﬁnity membrane-
bound peptide and the internalized quantity [4,18,19].
3.1.2. Cargo internalization via conjugates (1′–5′)
The amount of internalized cargo was measured after removing the
membrane-bound conjugates by TCEP treatment followed by trypsin
digestion. In both cell types, the amount of internalized cargo, Biot
(O2)-GGGG-C-PKCi, represented 1 to 2.5% of themembrane-bound con-
jugate. PKCi was internalized more efﬁciently into CHO-K1 cells (1.1 to
3.1 pmol) than into GAG-deﬁcient CHO cells. An example of this quan-
tiﬁcation is shown in Fig. 3C. The most potent vector with CHO-K1
cells were peptides (1′), (3′) and (5′), which led to the internalization
of 2.3, 2 and 3.1 pmol of PKCi, respectively, these peptides being 2- to
3-timesmore efﬁcient than peptides (2′) and (4′) (Fig. 4B). The amount
of PKCi internalized into CHO-pgsA-745 cells ranged from 0.5 to 1 pmol,
with the following rank of potency: (2′)=(4′)b(1′)=(3′)=(5′).
Comparison of the efﬁciency of these conjugates showed that in
both cell lines the Trp residues (indole side-chain) in the CPP sequence
are crucial for the cargo to be internalized, Ala and Ala-substituted ga-
lactosyl residues drastically reduce the internalization. Conjugate (5′)
with three galactosyl units on the N-terminus but with three trypto-
phans enters efﬁciently CHO cells. Conjugate (2′) with three alanines
is less efﬁcient than (1′) in entering CHO cells, in contrast to previously
reported for Jurkat cells [14]. Globally, the internalization results we re-
port herein are consistentwith the biological activity we had previously
observed when the CPPs were conjugated to the pro-apoptotic KLAK
peptide [13]. When conjugated to the CPPs containing three and two
Trp residues, the incubation of KLAK induced CHO-K1 cell death where-
as no effect on cell viabilitywas observedwhenKLAKwas conjugated to
the peptide containing three galactosylmoieties instead of tryptophans.
3.2. Probing the effect of the vector peptides (1–5) on DMPG lipid phase
transition by DSC
The interaction of peptides (1–5) with phospholipids was studied
by monitoring the way these peptides affect the Lβ′ gel phase to the
Pβ′ ripple phase (pre-transition Tpre) and the Pβ′ ripple phase to the
Lα ﬂuid phase (main transition, Tm) transitions of DMPG (thermo-
grams on Fig. 5). Although anionic lipids are not major constituents
in the external leaﬂet of eukaryotic cells, they are present and their
role becomes important when they get concentrated in larger mem-
brane areas, a process induced by other membrane active peptides
[26,27]. This aspect together with our previous observations on the
importance of electrostatic interactions between the peptide Arg6/
Trp3, an analog of peptide (1), and the lipids [28] led us to make
this lipid choice.
All the peptides affect the pre-transition, which was completely
abolished at the highest peptide concentrations. The thermograms
corresponding to P/L=1/10 are presented but, at this peptide con-
centration a high turbidity is often observed, corresponding to phe-
nomena such as vesicle fusion and/or precipitation. In the case of
the main transition, different behaviors could be observed depending
on the peptides. Peptides (2) and (4) did not induce signiﬁcant per-
turbation on the main transition of DMPG, and no shift of Tm were ob-
served. The enthalpy of the main transition only slightly increased,
due to little broadening of the peak. On the other hand, the main tran-
sition of DMPG was strongly affected by the addition of (1), (3) and
(5): the addition of peptide induced a shift of Tm to lower tempera-
tures, this shift being especially intense in the case of (1) and (5).
This decrease in Tm (Table 3) indicates that these three peptides in-
teract more favorably with the ﬂuid than the gel phase or in other
terms that these peptides have a ﬂuidizing effect on the model
bilayer.
Fig. 5. DSC thermograms illustrating the effect of the addition of peptides (1) to (5) to DMPG MLVs (1 mg/mL). The curves correspond to pure lipid and peptide to lipid ratios of 1/
100, 1/50, 1/25 and 1/10.
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ΔHm (Table 3) and induced an important broadening and ﬂattening
of the main transition peak. A change in ΔHm is the consequence of
the disruption of van der Waals interactions between the hydrocar-
bon chains. It shows that the three peptides were able to intercalate
between the fatty acid chains. Finally, addition of peptides (1), (3)
and (5) induced the splitting of the main transition peak, which has
been suggested in the literature to arise from the coexistence of
peptide-rich and peptide-poor domains in the bilayer [29–31].
DSC studies with DMPG provided information on the mode of in-
teraction with lipids both in the gel and ﬂuid phases and the way
they perturb the phase transition between these two states. For all
peptides investigated, the disappearance of the pre-transition arising
from the tilting of the hydrocarbon chains, suggests electrostatic in-
teractions between the cationic peptides (1–5) and the negatively
charged headgroups of DMPG. Peptides (1), (3) and (5) modify the
main transition involving the lipid chains, whereas peptides (2) and
(4) do not affect it at all, suggesting a rather superﬁcial contact be-
tween these two peptides and the lipid headgroups. The modiﬁcation
of lipid ﬂuidity by peptides (1), (3) and (5) may reﬂect their capacity
to intercalate between the fatty acid lipid chains. For these three pep-
tides, increasing the peptide concentrations induces the splitting of
the main transition peak, the difference in the Tm values of the two
peaks increases with concentration of peptides (1), (3) and (5), with-
out strongly affecting the area/population of the two corresponding
states. These two peaks can be assigned to different modes of peptide
association, as the DSC experiments were performed with pure
DMPG. The weak differences in the Tm values between these two
states exclude the existence of morphological equilibrium between
micelles, lamellar and hexagonal phases. In the lamellar phases, the
correlation time for lateral diffusion is greater than 10−5 s and the
formation of supramolecular assemblages occurs starting from very
small rafts (diameter b10 nm) to larger ones (from 30 to 230 nm)
in timescales in the range of 10−3 s [34,35]. Thus, within the experi-
ment time (several minutes for each scan), the lateral diffusion of
lipids and/or the formation of assemblages can readily occur leading
to homogeneous peptide distribution on the membrane surface.Table 3
Thermodynamic parameters obtained by DSC for pure DMPG and DMPG interacting
with peptides (1) to (5) at a peptide to lipid ratio of 1/25. T′ represents the second
peak maximum if a peak splitting is observed.
Tpre (°C) ΔHpre (kcal/mol) Tm (°C) ΔHm (kcal/mol) T′ (°C)
Pure DMPG 10.3 0.18 22.8 5.72 –
(1) – – 20.8 7.8 24.3
(2) – – 22.6 6.3 –
(3) – – 21.2 6 25.1
(4) 9.7 0.06 22.9 6.5 –
(5) – – 22.1 6.1 24.8Three different hypotheses may be evoked to explain the slow ex-
change rate between the two states observed in the DSC experiments
for peptides (1), (3) and (5), all originating from a nonhomogenous
distribution of the CPP on the lipid surfaces. Firstly, an equilibrium be-
tween monomeric versus aggregated forms of the CPP on the surfaces
of all MLVs bilayers may lead to the formation of “peptide-rich” and
“peptide-poor” domains, which may be achieved by an accumulation
of the CPP, provided the micromolar afﬁnity of the studied peptides
for negatively charged bilayers. Secondly, the presence of the CPPs
on both the external bilayer and inside ones, which perturb/interact
distinctly with the different curvatures of different lipid layers lead-
ing also to the splitting of the transition peak. Thirdly, the CPP may in-
teract with MLVs of different sizes, the peptides may indeed induce
the formation of smaller liposomes or micelles with different curva-
tures, this is quite common for peptides possessing even moderate
“detergent activity” [36–39]. During the DSC experiment, a total of
eight heating and cooling scans at 1 °C/min are performed, therefore
the peptides are interacting with the lipids in the gel and ﬂuid
phase or at the phase transition for long periods of time. Our hypoth-
esis is that during the runs, peptides (1), (3) and (5) are able to trans-
locate through the bilayer and therefore equilibrate between the
different layers of the MLVs, although the amounts of peptide in the
external layer and internal ones might be different. The different pep-
tide distribution among the different MLV layers can explain the split-
ting observed in the thermogram, but no lipid layer of the MLVs
remains unexposed to peptide as no Tm signal at a value correspond-
ing to pure DMPG is ever observed for peptides (1), (3) and (5).
When the main transition peak is not affected or split, the peptide
may remain only superﬁcially attached to the bilayer. In this study,
CPP (2) and (4) internalized poorly into CHO cells and they do not in-
duce any change in the Tm, as we have already observed for Arg6/Leu3
[28]. Arg9, which is an efﬁcient CPP, did not affect the Tm value of
DMPG MLVs, though a broadening of the transition peak could be ob-
served [28]. Arg9 probably presented a homogenous distribution on
all the lipid bilayers of DMPG MLVs, which is not the case for the
CPPs (1), (3) and (5). In the present work, it is difﬁcult to distinguish
between homogeneous peptide distribution due to peptide aggrega-
tion and distinct translocation processes through the MLVs with or
without fragmentation of the MLVs or concomitant phenomena.3.3. Binding of the peptides to DSPG LUVs probed by ITC
The interaction of peptides (1–5) with phospholipids was also stud-
ied using ITC (Table 4, Fig. 6). Aliquots of LUVs composed of pure DSPG
were injected into the calorimeter cell containing the peptide solution.
The anionic lipid DSPGwas used instead of DMPG becausewe have pre-
viously observed that the interaction of CPPs with DMPG often leads to
quite complex binding curves, probably due to the higher capacity of
this lipid to reorganize in different supramolecular assemblages. From
Table 4
Thermodynamic parameters of peptides binding to DSPG LUVs determined by ITC at
25 °C.
Peptides KA (M−1) KD (μM) ΔH (kJ/mol) ΔG (kJ/mol) ΔS (kJ/mol/K) n
(1) 12.5 105 0.80 −3.07 −44.7 0.140 5.7
(2) 2.53 105 3.96 −1.70 −40.8 0.131 3.8
(3) 9.50 105 1.05 −2.00 −44.1 0.141 4.2
(4) 1.02 105 9.80 −1.09 −38.5 0.126 6.2
(5) 2.17 105 4.6 −2.28 −40.4 0.128 4.9
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thalpy of the peptide to the liposome (ΔH), ii) an apparent KA repre-
senting the afﬁnity of the peptide for the liposome and iii) the
stoichiometry of binding n, i.e. the number of phospholipid per peptide.
The dissociation constant KD, the Gibbs free enthalpy (ΔG) and the en-
tropy (ΔS) of binding were derived from the KA and ΔH. The binding
isotherms are displayed in Fig. 6 and the derived thermodynamic data
are given in Table 4. For all the peptides, binding to DSPG LUVs was an
exothermic process, and therefore enthalpy driven. Peptide (1) had
the strongest afﬁnity for the liposomes followed by (3). The afﬁnity of
(2) was intermediate and peptides (4) and (5) had weaker afﬁnities.
Peptide (4) had more than ten times less afﬁnity for the DSPG LUVs
compared to (1). The lowest ΔH corresponds to (1) and (5) (both
with three Trp) whereas the highest ΔH correspond to (2) and (4)
(no Trp), peptide (3) (with two Trp) has intermediate ΔH. The stoichi-
ometry of binding varied between 4 and 6, being around the number of
guanidinium side-chains for the peptide.
The interactions of CPPs (1), (3) and (5) led to more favorable en-
thalpy when compared with peptides (2) and (4), and there is a quite
good correlation between the number of Trp residues in the peptide
and the enthalpy (favorable) associated with peptide/lipid interac-
tion. The energetically favorable transfer of Trp residues from an
aqueous to a hydrophobic environment (membrane core) can explain
the increase in enthalpy with the number of Trp residues. Most inter-
esting to quote is that such favorable enthalpy seems to affect the
peptides' capacity to enter cells. Indeed, there is a certain relationship
between the enthalpy and the CPP internalization efﬁciency in CHO
cells. Thus, the favorable enthalpy associated with Trp transfer into
the lipid membrane may be the prominent driving force among
others to insert into the membrane and induce the necessary lipid bi-
layer perturbation for cellular internalization.
3.4. Peptide insertion in monolayers and interface morphology
The insertion of the peptides in monolayers composed of pure
DMPC or DMPC/DMPG (80/20) was studied by following the surface
pressure at the air/buffer interface in a Langmuir trough using theFig. 6. Isothermal titration of DSPG LUVs (6.24 mM or 3.12 mM) into peptides (1) to (5) (pe
heat of reaction measured by peak integration as a function of lipid/peptide ratio. The solid
summarized in Table 4.Whilelmy method. The monolayer thickness was evaluated to be
around 13 Å. None of the peptides induced any change in the surface
pressure when injected underneath a DMPC monolayer. Different be-
haviors were observed when the peptides where injected beneath the
DMPC/DMPG monolayers. Comparison of the peptides (1 to 5)
showed that only peptides (1) and (5) induced an increase
(0.3 mN/m to 0.6 mN/m per injection) in surface pressure, showing
that they were able to slightly insert into the DMPC/DMPGmonolayer
(data not shown). However, these variations remained weak com-
pared to the strong increase in the surface pressure we previously
reported [40] for Substance P, a primary amphipathic neuropeptide,
or as reported for other CPPs [41]. The SP backbone was shown to
penetrate into the lipidic layer, suggesting that in the case of CPPs
(1) and (5) only a limited insertion of the tryptophan side chains
into the lipid layer should occur. For penetratin it has been proposed
that its two tryptophans, orientated parallel to the membrane, anchor
the peptide on the surface [42–44]. In membrane mimetic environ-
ments penetratin is more or less helical with its axis parallel to the
membrane surface, as previously reported [32] and further conﬁrmed
by polarized-light spectroscopy [45].
At the same time, the morphology of the interface was monitored
using Imaging Ellipsometry. After injection of the different peptides,
domains corresponding to different gray level intensities on the
image (Fig. 7) appeared. The domains were comparable for every
peptide with very irregular shapes and growing in size along time.
In some cases for peptides (1), (2) and (3), the thickness of the do-
main could be evaluated from their reﬂection intensity around 35 Å.
Such domains may be related with the more favorable interaction
and subsequent recruitment of anionic lipids by the peptide as al-
ready observed by DSC studies [26,27].
3.5. Peptide structure determined by ATR spectroscopy
ATR spectroscopy allowed studying the structure of the peptides
in solution as well as in the presence of model phospholipid mem-
branes. In solution, after the subtraction of the buffer absorption,
the amide I band was well deﬁned at 1643 cm−1, showing that all
the peptides were mainly random in buffer. In the presence of
multi-bilayers deposited on the ATR crystal, a shift in position for
the amide bands was observed (Table 5). Peptides (2) and (5) had
well deﬁned amide I bands at 1658 cm−1 and 1657 cm−1, respective-
ly for both p and s polarizations, showing that these two peptides
have a helical structure in contact with the model membrane. For
peptides (1), (3) and (4), the situation was less clear. For p polariza-
tion, the amide I bands are all located around 1652 cm−1, showing
helical content. However for s polarization, the position of the
amide I bands corresponds to a random coil. Therefore, there isptide concentration 100 μM, except (5) 48 μM) at 25 °C. The lower curves represent the
lines represent the best ﬁt to experimental data. The thermodynamic parameters are
Fig. 7. Ellipsometry images of a DMPC/DMPG (80/20) monolayer at a water–air inter-
face and after injection of peptides (1) to (5) in the subphase. The monolayer appears
in gray and domains in dark, except for peptide (4) where the monolayer appears in
dark and the domain in gray.
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ably more oriented along the z axis bilayer and the random coil with-
out speciﬁc orientation. The accumulation of peptides (1–5) in the
membrane shifted the random coil conformations observed in solu-
tion towards helical structures as revealed by ATR spectroscopy.
Thus, these ﬁve CPP (1–5) accumulate on the surface, lying probably
parallel to the membrane according to their secondary amphipathic
structure, and depending on the presence of the tryptophan side-
chains a subsequent insertion of the indoles may allow the transfer
of the CPP and its cargo into the lipid bilayer.
4. Conclusion
With the series of CPPs studied here we have shown that trypto-
phan residues play a key role in the insertion of a CPP and its conju-
gate in the membrane, and that galactosyl residues hamper the
internalization when introduced in the middle of the amphipathic
secondary structure of a CPP but not on the C-ter, as long as trypto-
phan residues are still present in the sequence. The insertion of
these CPPs into membrane models is enthalpy driven and correlates
with the number of tryptophans in the sequence of these secondary
amphipathic CPPs. Reported NMR studies by our laboratory on an an-
alog of Arg6/Trp3 have indicated the existence of π-cation interactions
between the Trp and Arg residues of this CPP [32]. Tryptophan resi-
dues via the π-cation interaction may promote/allow the crossing of
the lipidic membrane core by the cationic peptide (or peptide rich
in cationic residues), a process that would be highly unfavorable oth-
erwise. Such contact not being possible in the case of peptide Arg6/
Ala3, and in the case of Arg6/Leu3 peptide [28], both peptides fail to
enter cells. Deshayes et al. have also proposed that tryptophans areTable 5
Amide I band position on ATR spectra for p and s polarizations for peptides (1) to (5) in
contact with multi-bilayers composed of DMPC/DMPG (80/20) supported on the ATR
crystal and the associated probable secondary structure.
Amide I band position (cm−1) (p/s polarization) Probable structure
(1) 1652/1639 α-Helix/Random Coil
(2) 1658/1658 α-Helix
(3) 1653/1641 α-Helix/Random Coil
(4) 1652/1646 α-Helix/Random Coil
(5) 1657/1657 α-Heliximportant in the function of their lead CPP (CADY), even though
“the reasons of their importance are unclear” [33]. Chan et al. have
highlighted the crucial chemical properties of Arg and Trp residues
in antimicrobial peptides. They proposed that Trp should have a dis-
tinct preference for the interfacial region of lipid bilayers, while Arg
residues allow adequate interactions with the anionic components
of bacterial membranes [46].
We have observed with DMPG MLVs that some peptides, which
are efﬁcient CPPs, lead to Tm splitting, suggesting that during the
DSC experiments these CPPs may distribute non-homogeneously in
the lipids, a process due to either the peptide internalization into
the internal MLVs bilayers at different levels and/or peptide auto-
association. Peak splitting in the main lipid phase transition may
help identifying efﬁcient CPPs. However, this might not be a prerequi-
site, as efﬁcient CPPs may not induce a Tm splitting, depending prob-
ably on the overall distribution of the CPP within the MLV bilayers,
and/or their propensity to auto-associate. The CPPs investigated here-
in present a certain propensity to aggregate in contact with the lipid
surface, whether this property is related to the observed differences
in terms of uptake needs further studies.
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